Results 191 to 200 of about 69,808 (218)

Molecular imaging in oncology: Current impact and future directions

Ca-A Cancer Journal for Clinicians, 2022
Steven P Rowe, Martin G Pomper
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

[Other anti-retroviral agents].

Enfermedades infecciosas y microbiologia clinica, 1997
B, Clotet, P, Labarga, J, Portilla, S, Echevarría   +3 more
openaire   +1 more source

872 IMPACT OF ANTI-RETROVIRAL AGENTS ON SUSCEPTIBILITY TO AND REPLICATION OF HEPATITIS C VIRUS IN VITRO

Journal of Hepatology, 2012
L. Sandmann, D. Back, H. Wedemeyer, M.P. Manns, T. Pietschmann, T. von Hahn, S. Ciesek   +6 more
openaire   +1 more source

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul Parikh
exaly  

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Stephanie Lheureux, Marsela Braunstein, Amit M Oza   +2 more
exaly  

Improving the outcome for children with cancer: Development of targeted new agents

Ca-A Cancer Journal for Clinicians, 2015
Peter C Adamson
exaly  

4908438 Daunorubicin, doxorubicin and pharmaceutically acceptable salts therefore as anti-retroviral agents

General Pharmacology: The Vascular System, 1990
openaire   +1 more source

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly